Clarivate Plc (CLVT)
Market Cap | 4.02B |
Revenue (ttm) | 2.62B |
Net Income (ttm) | -1.11B |
Shares Out | 723.53M |
EPS (ttm) | -1.65 |
PE Ratio | n/a |
Forward PE | 7.20 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 2,432,418 |
Open | 5.53 |
Previous Close | 5.53 |
Day's Range | 5.42 - 5.59 |
52-Week Range | 5.19 - 10.03 |
Beta | 1.20 |
Analysts | Hold |
Price Target | 7.69 (+38.31%) |
Earnings Date | Aug 1, 2024 |
About CLVT
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academi... [Read more]
Financial Performance
In 2023, Clarivate's revenue was $2.63 billion, a decrease of -1.17% compared to the previous year's $2.66 billion. Losses were -$986.60 million, -75.55% less than in 2022.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for CLVT stock is "Hold." The 12-month stock price forecast is $7.69, which is an increase of 38.31% from the latest price.
News
Clarivate Identifies Six Breakthrough MedTech Trends in 2024 Set to Unlock New Industry Opportunities
New report highlights challenges and opportunities in resilient MedTech industry LONDON , July 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intellige...
Clarivate Report Demonstrates Societal Impact of Digital Health Research and Innovation Growth
LONDON , June 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released a Global Research Report from the Institute for Scientific ...
Clarivate Launches IP Collaboration Hub
Enabling users to save time and reduce risks in the IP filing and prosecution process LONDON , June 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative int...
Clarivate Reveals World's Leading and Trusted Journals with the 2024 Journal Citation Reports
Adds Emerging Sources Citation Index™ for a simplified and unified category view LONDON , June 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intellige...
Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New Companies to Watch Report
Emerging standouts set to transform drug discovery and development, revolutionize cancer treatment, and capture big pharma interest highlighted in third annual report LONDON , June 19, 2024 /PRNewswir...
Clarivate Launches Research Horizon Navigator to Pinpoint Future Breakthrough Areas
Insights from the new InCites Benchmarking & Analytics module support strategic investment and demonstrate impact LONDON , June 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global pro...
Clarivate Expands Real-World Data Offering with Addition of Social Determinant of Health (SDoH) Attributes from HealthWise Data
Strategic collaboration enhances insight into patient demographics and behaviors, enabling analytical precision in addressing population health outcomes LONDON, May 31, 2024 /PRNewswire/ -- Clarivate ...
Clarivate Announces Conversion Date and Conversion Rate for Series A Mandatory Convertible Preferred Shares
LONDON , May 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT; CLVT PR A) ("Clarivate"), a leading global provider of transformative intelligence, announced today that its 5.25% Series A Mandatory C...
Clarivate Celebrates 500 Institutions Adopting Rialto Marketplace Solution
Transforming the way libraries select, acquire and manage their collections of academic books LONDON , May 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformati...
Clarivate to Present at Upcoming Investor Conferences in June 2024
LONDON , May 29, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today announced that the Company will present...
Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024
New report highlights innovations poised to drive significant clinical and market impact LONDON , May 22, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative in...
New Clarivate Report Indicates Solid Growth in 2024 Global Trademark Filing Activity
Analyzing six of the key trademark registers from around the world LONDON , May 21, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today rel...
Clarivate Launches AI-Enhanced Solution to Accelerate Trademark Watching
Providing faster and more accurate answers to critical business questions LONDON , May 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, la...
New Clarivate Report Reveals that the U.S., Germany and Mainland China have the most Non-Practicing Entity Litigation
Infringement declined globally from 2012 to 2019 LONDON , May 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released the 2024 Non...
OMRON Selects IPfolio from Clarivate
IP solution maximizes operational efficiency for leading automation company LONDON , May 9, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, a...
Clarivate Reports First Quarter 2024 Results
— Reaffirms 2024 Outlook — LONDON , May 8, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported resu...
Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis
Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for precise market sizing and patient population analysis LONDON , May 7, 202...
Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success
Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics LONDON , May 2, 2024 /PRNewswire/ -- ...
Clarivate Declares Dividend on Mandatory Convertible Preferred Shares
LONDON , May 1, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT; CLVT PR A) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its board of directors declared...
BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report
Three-part report investigates rapid pipeline growth, partnerships, clinical trials , and patient access challenges in cancer treatment LONDON , April 30, 2024 /PRNewswire/ -- BioWorld™ published by ...
Clarivate joins United Nations SDG Publishers Compact
LONDON , April 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces it has signed the United Nations Sustainable Development Go...
Clarivate Acquires Global QMS, Inc., Expanding Life Sciences & Healthcare Segment into New Markets
Acquisition supports critical client workflow and reporting needs with proprietary SaaS platform, automating regulatory report authoring and compliance across manufacturing operations, supply chain an...
Clarivate Launches LatAm Market Tracking Solution in Partnership with Global Healthcare Intelligence Enabling Real-Time Tracking of Medical Device Markets
New solution offers comprehensive tracking and analysis of market share and size in Brazil, Colombia, Argentina, Chile, Peru and Ecuador LONDON , April 17, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLV...
Clarivate to Report First Quarter 2024 Results on May 8, 2024
LONDON , April 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the first quarter...
Clarivate Leadership Presents at Recent Investor Conferences
--- Clarivate CFO and Segment Presidents Discuss Growth Initiatives Including Generative AI Strategies --- LONDON , April 1, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider ...